Table 2

Baseline Demographics in the Included Studies

Total PatientsWomenMenp Value
Age, yrs36,16082.7 ± 1.281.8 ± 1.40.0001
DM, %36,16034.9 ± 10.938.6 ± 12.30.0001
HTN, %10,12789.7 ± 9.387.9 ± 11.50.0004
AF, %30,14138.1 ± 1.042.1 ± 1.10.0004
Prior stroke, %36,16013.4 ± 6.515.4 ± 7.50.0001
Prior MI, %10,06716.6 ± 4.730.9 ± 10.60.0005
CAD, %12,13151.9 ± 19.774.4 ± 20.70.0004
PAD, %33,25628.2 ± 10.737.2 ± 11.50.0001
Prior PCI, %32,19329.9 ± 4.241.9 ± 4.80.0002
Prior CABG, %34,75715.9 ± 6.645.5 ± 13.90.0002
HF NYHA class III/IV, %31,59782.9 ± 6.580.8 ± 6.40.0001
Balloon-expandable valve, %39,36376.2 ± 38.772.7 ± 38.70.0001
Self-expandable valve, %40,23923.6 ± 38.426.1 ± 38.60.0001
Transfemoral access, %37,70262.7 ± 16.468.8 ± 13.70.0001
Transapical access, %28,33632.4 ± 17.526.8 ± 14.70.0001
LVEF, %34,60156.9 ± 2.950.7 ± 2.70.0002
CKD, %9,50530.6 ± 28.326.9 ± 25.60.0004
COPD, %6,52927.5 ± 10.733.9 ± 10.80.0006
EUROSCORE11,92420.3 ± 5.322.2 ± 5.70.0003

Values are n or weighted mean ± SD. AF = atrial fibrillation; CABG = coronary artery bypass grafting; CAD = coronary artery disease; CKD = chronic kidney disease; COPD = chronic obstructive pulmonary disease; DM = diabetes mellitus; EUROSCORE = European System for Cardiac Operative Risk Evaluation score; HF = heart failure; HTN = hypertension; LVEF = left ventricular ejection fraction; MI = myocardial infarction; NYHA = New York Heart Association; PAD = peripheral arterial disease; PCI = percutaneous coronary intervention.